首页>投融资
Xenocor
A轮
Xenocor Inc is a developer of single-use high-definition laparoscopy devices designed to offer safe and superior high-definition imagery. The company offers single-use, fog-free, high-definition laparoscopic imaging equipment that provides the benefits of minimally invasive surgery and can be operated independently of a power grid, enabling physicians at hospitals, surgery centres, and medical outreach organizations to perform laparoscopic procedures at low cost while delivering high value
基本信息
-
公司全称Xenocor Inc
-
类型医疗器械研发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址630 S Komas Dr Ste 200 SALT LAKE CITY UTAH 84108-1262; US;
-
联系电话435-680-9782
-
邮箱info@xenocor.com
-
成立时间2014-01-01
投融资
-
2023-04-18A轮1000万美元GenHenn Venture Fund IBaranco InvestmentsBarvest VenturesPatel Family Investment
-
2021-06-22战略投资未透露Barvest Ventures
-
2021-04-27A轮未透露Growing Impact Ventures
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
PBS Biotech 是一次性生物反应器系统的领先制造商。PBS 生物反应器利用专有的“Vertical-Wheel TM ”技术来支持剪切敏感的细胞治疗产品。PBS Biotech愿景是成为世界上同种异体细胞疗法的标准制造平台。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息